Caspase-cleaved glial fibrillary acidic protein within cerebellar white matter of the Alzheimer's disease brain

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 1, 2013, Pages 41-48

  Rohn, Troy T ^a   Catlin, Lindsey W ^a   Poon, Wayne W ^b  

^a BOISE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Caspase; Cerebellum; Gfap; Immunohistochemistry; Neurofibrillary tangles; PHF 1; TUNEL

Indexed keywords

CASPASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BETA AMYLOID; CEREBELLUM; FLUORESCENCE MICROSCOPY; GFAP; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MYELINATED NERVE; NEUROFIBRILLARY TANGLE; NICK END LABELING; PATHOLOGY; PHF-1; PHYSIOLOGY;

ALZHEIMER'S DISEASE; BETA AMYLOID; CASPASE; CEREBELLUM; GFAP; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLES; PHF-1; TUNEL;

ALZHEIMER DISEASE; APOPTOSIS; CASPASES; CEREBELLUM; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, FLUORESCENCE; NERVE FIBERS, MYELINATED;

EID: 84870450404     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bastian AJ. Moving, sensing and learning with cerebellar damage. Curr Opin Neurobiol 2011; 21: 596-601.
2. Marr D. A theory of cerebellar cortex. J Physiol 1969; 202: 437-470.
3. Fine EJ, Ionita CC and Lohr L. The history of the development of the cerebellar examination. Semin Neurol 2002; 22: 375-384.
4. Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, Schmidtmann I, Gerhard A, Schreckenberger M and Bartenstein P. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 2008; 164: 143-153.
5. Soonawala D, Amin T, Ebmeier KP, Steele JD, Dougall NJ, Best J, Migneco O, Nobili F and Scheidhauer K. Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage 2002; 17: 1193-1202.
6. Andersen K, Andersen BB and Pakkenberg B. Stereological quantification of the cerebellum in patients with Alzheimer's disease. Neurobiol Aging 2012; 33: 197 e111-120.
7. Azzarelli B, Muller J, Ghetti B, Dyken M and Conneally PM. Cerebellar plaques in familial Alzheimer's disease (Gerstmann-Straussler-Scheinker variant?). Acta Neuropathol 1985; 65: 235-246.
8. Aikawa H, Suzuki K, Iwasaki Y and Iizuka R. Atypical Alzheimer's disease with spastic paresis and ataxia. Ann Neurol 1985; 17: 297-300.
9. Fukutani Y, Cairns NJ, Rossor MN and Lantos PL. Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation. J Neurol Sci 1997; 149: 177-184.
10. Joachim CL, Morris JH and Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 1989; 135: 309-319.
11. Li YT, Woodruff-Pak DS and Trojanowski JQ. Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites. Neurobiol Aging 1994; 15: 1-9.
12. Suttanon P, Hill KD, Said CM, Logiudice D, Lautenschlager NT and Dodd KJ. Balance and mobility dysfunction and falls risk in older people with mild to moderate Alzheimer disease. Am J Phys Med Rehabil 2012; 91: 12-23.
13. Pedroso RV, Coelho FG, Santos-Galduroz RF, Costa JL, Gobbi S and Stella F. Balance, executive functions and falls in elderly with Alzheimer's disease (AD): a longitudinal study. Arch Gerontol Geriatr 2012; 54: 348-351.
14. Mazoteras Munoz V, Abellan van Kan G, Cantet C, Cortes F, Ousset PJ, Rolland Y and Vellas B. Gait and balance impairments in Alzheimer disease patients. Alzheimer Dis Assoc Disord 2010; 24: 79-84.
15. Mirolsky-Scala G and Kraemer T. Fall management in Alzheimer-related dementia: a case study. J Geriatr Phys Ther 2009; 32: 181-189.
16. Alexander NB, Mollo JM, Giordani B, Ashton-Miller JA, Schultz AB, Grunawalt JA and Foster NL. Maintenance of balance, gait patterns, and obstacle clearance in Alzheimer's disease. Neurology 1995; 45: 908-914.
17. Mouser PE, Head E, Ha KH and Rohn TT. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am J Pathol 2006; 168: 936-946.
18. Rohn TT, Wirawan E, Brown RJ, Harris JR, Masliah E and Vandenabeele P. Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer's disease brain. Neurobiol Dis 2011; 43: 68-78.
19. Acarin L, Villapol S, Faiz M, Rohn TT, Castellano B and Gonzalez B. Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation. Glia 2007; 55: 954-965.
20. Rohn TT and Catlin LW. Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain. PLoS One 2011; 6: e20495.
21. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI and Cryns VL. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 2003; 100: 10032-10037.
22. Rohn TT. The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities. Apoptosis 2010; 15: 1403-1409.
23. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC and Wegiel J. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 2004; 25: 663-674.
24. Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, Garwood C, Drew D, Shaw PJ and Ince PG. Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neurosci Lett 2011; 505: 25-30.
25. Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, Schultzberg M and Bogdanovic N. Blood-brain barrier alterations in age ing and dementia. J Neurol Sci 2009; 283: 99-106.
26. Berzin TM, Zipser BD, Rafii MS, Kuo-Leblanc V, Yancopoulos GD, Glass DJ, Fallon JR and Stopa EG. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 2000; 21: 349-355.
27. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V and Stopa EG. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging 2007; 28: 977-986.
28. Pihlaja R, Koistinaho J, Malm T, Sikkila H, Vainio S and Koistinaho M. Transplanted Astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Glia 2008; 56: 154-163.
29. Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P and Veerhuis R. Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloidassociated proteins. Glia 2010; 58: 1235-1246.